Feb 22 (Reuters) - Fluicell AB FLUIC.ST :
* ANNOUNCED ON TUESDAY THAT IT HAS ENTERED INTO NEW
AGREEMENT WITH
HOFFMANN-LA ROCHE
* COLLABORATION BUILDS ON PREVIOUS PILOT PROJECT COMPLETED
IN 2022
* PROJECT SPANS OVER TEN MONTHS, WILL EXPLORE OPTIMIZATION
OF
BIOPRINTED CARDIAC TISSUES FOR SAFETY PHARMACOLOGY
* DURING PROJECT, ROCHE WILL ASSIST WITH MATERIAL COSTS OF
ABOUT
SEK 0.5 MLN, FLUICELL WILL CONDUCT STUDIES, TESTS
* PROJECT IS EXPECTED TO BE COMPLETED IN DEC, 2023
Source text for Eikon: urn:newsml:reuters.com:*:nWkr2B2wGk
Further company coverage: FLUIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))